Two Sigma Investments, LP Dexcom Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Dexcom Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 54,800 shares of DXCM stock, worth $4.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

54,800

Previous 752,323 92.72%

Holding current value

$4.39 Million

Previous $85.3 Million 95.7%

% of portfolio

0.01%

Previous 0.21%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $4.65 Million - $8.44 Million	72,680 Added 9.66%	825,003 $55.3 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $81.5 Million - $104 Million	738,397 Added 5302.29%	752,323 $85.3 Million
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $193,146 - $236,909	1,691 Added 13.82%	13,926 $1.93 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $10.9 Million - $17.9 Million	-143,892 Reduced 92.16%	12,235 $1.52 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $5.99 Million - $9.6 Million	-69,622 Reduced 30.84%	156,127 $14.6 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $22.1 Million - $25.7 Million	-196,180 Reduced 46.5%	225,749 $29 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $36.3 Million - $42.9 Million	349,139 Added 479.65%	421,929 $49 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $6.19 Million - $8.93 Million	72,790 New	72,790 $8.24 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $52.5 Million - $103 Million	772,611 Added 4085.94%	791,520 $59 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $32.1 Million - $44.4 Million	-340,977 Reduced 94.75%	18,909 $9.67 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $45.4 Million - $56.9 Million	349,749 Added 3450.22%	359,886 $193 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $985,680 - $1.32 Million	9,237 Added 1026.33%	10,137 $5.54 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $5.8 Million - $7.77 Million	-74,327 Reduced 98.8%	900 $333,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $2.8 Million - $4.7 Million	44,624 Added 145.82%	75,227 $30.5 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $3.65 Million - $5.78 Million	-76,460 Reduced 71.42%	30,603 $8.24 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $2.36 Million - $3.69 Million	64,413 Added 151.03%	107,063 $23.4 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $1.79 Million - $2.5 Million	-64,237 Reduced 60.1%	42,650 $6.39 Million
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $17.5 Million - $23.8 Million	-624,172 Reduced 85.38%	106,887 $12.7 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $16.9 Million - $23.4 Million	626,098 Added 596.51%	731,059 $87.6 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $2.45 Million - $3.85 Million	104,961 New	104,961 $15 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Dexcom Inc Transaction History